首页 | 本学科首页   官方微博 | 高级检索  
     


Dietary and Pharmacological Modification of Fibroblast Growth Factor-23 in Chronic Kidney Disease
Affiliation:1. Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands;2. Department of Endocrine Surgery, University of Sydney, Endocrine Surgery Unit, Sydney, Australia;3. Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands;4. Department of Renal Medicine, Royal North Shore Hospital, St Leonards, Australia;1. Department of Healthcare Epidemiology, School of Public Health at Graduate School of Medicine, Kyoto University, Kyoto, Japan;2. Institute for Advancement of Clinical and Translational Science (iACT), Kyoto University Hospital, Kyoto, Japan;3. Institute for Health Outcomes and Process Evaluation Research (iHope International), Tokyo, Japan;4. Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan;5. Division of Nephrology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan;6. Fukushima Medical University, Fukushima, Japan;1. Centre de Référence des Maladies Rénales Rares, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France;2. Department of Nephrology, Centre Hospitalier Lyon Sud, Pierre-Bénite, France;3. NEPHROCARE Tassin-Charcot, Ste Foy les Lyon, France;4. CARMEN, CENS and Université de Lyon, Lyon, France
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号